1-3 of 3
Naoto Ohi
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Synergistic Antitumor Effect of a Novel First-in-Class Small Molecule OPB-111077 That Inhibits Mitochondrial Oxidative Phosphorylation in Combination with Alkylating Agent

Emiri Omori Takaki, Naoto Ohi
Journal: Blood
Blood (2024) 144 (Supplement 1): 2792.
https://doi.org/10.1182/blood-2024-199858
Published: 2024
Journal Articles

Combination Therapy Strategy for Lymphoma Based on Cancer Energy Metabolism of OPB-111077, a Novel Antitumor Agent Inhibiting Mitochondrial Oxidative Phosphorylation

Naoto Ohi, Mitsuhiro Okuno, Hideo Tanaka, Tadaaki Ohtani
Journal: Blood
Blood (2021) 138 (Supplement 1): 4363.
https://doi.org/10.1182/blood-2021-148979
Published: 2021
Journal Articles

A Novel Direct STAT3 Inhibitor OPB-31121 Induces Tumor-Specific Growth Inhibition In a Wide Range of Hematopoietic Malignancies and Effectively Suppresses the Chemotherapy Resistant Quiescent Cells In Vivo

Fumihiko Hayakawa, MD, PhD, Keiki Sugimoto, Shingo Kurahashi, MD, Hironori Matsuyama, Yasuo Harada, Norikazu Hashimoto, Naoto Ohi, Takeshi Kodama, Takumi Sumida, Tomohiro Kinoshita, MD, PhD, Tomoki Naoe, MD, PhD
Journal: Blood
Blood (2010) 116 (21): 3277.
https://doi.org/10.1182/blood.V116.21.3277.3277
Published: 2010